IBDEI3GH ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,58134,1,3,0)
;;=3^Drug-Induced Glaucoma,Right Eye,Unspec Stage
;;^UTILITY(U,$J,358.3,58134,1,4,0)
;;=4^H40.61X0
;;^UTILITY(U,$J,358.3,58134,2)
;;=^5005906
;;^UTILITY(U,$J,358.3,58135,0)
;;=H40.61X2^^272^2901^41
;;^UTILITY(U,$J,358.3,58135,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58135,1,3,0)
;;=3^Drug-Induced Glaucoma,Right Eye,Moderate Stage
;;^UTILITY(U,$J,358.3,58135,1,4,0)
;;=4^H40.61X2
;;^UTILITY(U,$J,358.3,58135,2)
;;=^5005908
;;^UTILITY(U,$J,358.3,58136,0)
;;=H40.61X3^^272^2901^42
;;^UTILITY(U,$J,358.3,58136,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58136,1,3,0)
;;=3^Drug-Induced Glaucoma,Right Eye,Severe Stage
;;^UTILITY(U,$J,358.3,58136,1,4,0)
;;=4^H40.61X3
;;^UTILITY(U,$J,358.3,58136,2)
;;=^5133509
;;^UTILITY(U,$J,358.3,58137,0)
;;=H40.61X4^^272^2901^39
;;^UTILITY(U,$J,358.3,58137,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58137,1,3,0)
;;=3^Drug-Induced Glaucoma,Right Eye,Indeterminate Stage
;;^UTILITY(U,$J,358.3,58137,1,4,0)
;;=4^H40.61X4
;;^UTILITY(U,$J,358.3,58137,2)
;;=^5005909
;;^UTILITY(U,$J,358.3,58138,0)
;;=H40.62X1^^272^2901^35
;;^UTILITY(U,$J,358.3,58138,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58138,1,3,0)
;;=3^Drug-Induced Glaucoma,Left Eye,Mild Stage
;;^UTILITY(U,$J,358.3,58138,1,4,0)
;;=4^H40.62X1
;;^UTILITY(U,$J,358.3,58138,2)
;;=^5005911
;;^UTILITY(U,$J,358.3,58139,0)
;;=H40.62X0^^272^2901^38
;;^UTILITY(U,$J,358.3,58139,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58139,1,3,0)
;;=3^Drug-Induced Glaucoma,Left Eye,Unspec Stage
;;^UTILITY(U,$J,358.3,58139,1,4,0)
;;=4^H40.62X0
;;^UTILITY(U,$J,358.3,58139,2)
;;=^5005910
;;^UTILITY(U,$J,358.3,58140,0)
;;=H40.62X2^^272^2901^36
;;^UTILITY(U,$J,358.3,58140,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58140,1,3,0)
;;=3^Drug-Induced Glaucoma,Left Eye,Moderate Stage
;;^UTILITY(U,$J,358.3,58140,1,4,0)
;;=4^H40.62X2
;;^UTILITY(U,$J,358.3,58140,2)
;;=^5005912
;;^UTILITY(U,$J,358.3,58141,0)
;;=H40.62X3^^272^2901^37
;;^UTILITY(U,$J,358.3,58141,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58141,1,3,0)
;;=3^Drug-Induced Glaucoma,Left Eye,Severe Stage
;;^UTILITY(U,$J,358.3,58141,1,4,0)
;;=4^H40.62X3
;;^UTILITY(U,$J,358.3,58141,2)
;;=^5133510
;;^UTILITY(U,$J,358.3,58142,0)
;;=H40.62X4^^272^2901^34
;;^UTILITY(U,$J,358.3,58142,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58142,1,3,0)
;;=3^Drug-Induced Glaucoma,Left Eye,Indeterminate Stage
;;^UTILITY(U,$J,358.3,58142,1,4,0)
;;=4^H40.62X4
;;^UTILITY(U,$J,358.3,58142,2)
;;=^5005913
;;^UTILITY(U,$J,358.3,58143,0)
;;=H40.63X0^^272^2901^33
;;^UTILITY(U,$J,358.3,58143,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58143,1,3,0)
;;=3^Drug-Induced Glaucoma,Bilateral,Unspec Stage
;;^UTILITY(U,$J,358.3,58143,1,4,0)
;;=4^H40.63X0
;;^UTILITY(U,$J,358.3,58143,2)
;;=^5005914
;;^UTILITY(U,$J,358.3,58144,0)
;;=H40.63X1^^272^2901^30
;;^UTILITY(U,$J,358.3,58144,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58144,1,3,0)
;;=3^Drug-Induced Glaucoma,Bilateral,Mild Stage
;;^UTILITY(U,$J,358.3,58144,1,4,0)
;;=4^H40.63X1
;;^UTILITY(U,$J,358.3,58144,2)
;;=^5005915
;;^UTILITY(U,$J,358.3,58145,0)
;;=H40.63X2^^272^2901^31
;;^UTILITY(U,$J,358.3,58145,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58145,1,3,0)
;;=3^Drug-Induced Glaucoma,Bilateral,Moderate Stage
;;^UTILITY(U,$J,358.3,58145,1,4,0)
;;=4^H40.63X2
;;^UTILITY(U,$J,358.3,58145,2)
;;=^5005916
;;^UTILITY(U,$J,358.3,58146,0)
;;=H40.63X3^^272^2901^32
;;^UTILITY(U,$J,358.3,58146,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58146,1,3,0)
;;=3^Drug-Induced Glaucoma,Bilateral,Severe Stage
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3GH 3991 printed Sep 15, 2024@22:12:30 Page 2
IBDEI3GH ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,58134,1,3,0)
+2 ;;=3^Drug-Induced Glaucoma,Right Eye,Unspec Stage
+3 ;;^UTILITY(U,$J,358.3,58134,1,4,0)
+4 ;;=4^H40.61X0
+5 ;;^UTILITY(U,$J,358.3,58134,2)
+6 ;;=^5005906
+7 ;;^UTILITY(U,$J,358.3,58135,0)
+8 ;;=H40.61X2^^272^2901^41
+9 ;;^UTILITY(U,$J,358.3,58135,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,58135,1,3,0)
+12 ;;=3^Drug-Induced Glaucoma,Right Eye,Moderate Stage
+13 ;;^UTILITY(U,$J,358.3,58135,1,4,0)
+14 ;;=4^H40.61X2
+15 ;;^UTILITY(U,$J,358.3,58135,2)
+16 ;;=^5005908
+17 ;;^UTILITY(U,$J,358.3,58136,0)
+18 ;;=H40.61X3^^272^2901^42
+19 ;;^UTILITY(U,$J,358.3,58136,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,58136,1,3,0)
+22 ;;=3^Drug-Induced Glaucoma,Right Eye,Severe Stage
+23 ;;^UTILITY(U,$J,358.3,58136,1,4,0)
+24 ;;=4^H40.61X3
+25 ;;^UTILITY(U,$J,358.3,58136,2)
+26 ;;=^5133509
+27 ;;^UTILITY(U,$J,358.3,58137,0)
+28 ;;=H40.61X4^^272^2901^39
+29 ;;^UTILITY(U,$J,358.3,58137,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,58137,1,3,0)
+32 ;;=3^Drug-Induced Glaucoma,Right Eye,Indeterminate Stage
+33 ;;^UTILITY(U,$J,358.3,58137,1,4,0)
+34 ;;=4^H40.61X4
+35 ;;^UTILITY(U,$J,358.3,58137,2)
+36 ;;=^5005909
+37 ;;^UTILITY(U,$J,358.3,58138,0)
+38 ;;=H40.62X1^^272^2901^35
+39 ;;^UTILITY(U,$J,358.3,58138,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,58138,1,3,0)
+42 ;;=3^Drug-Induced Glaucoma,Left Eye,Mild Stage
+43 ;;^UTILITY(U,$J,358.3,58138,1,4,0)
+44 ;;=4^H40.62X1
+45 ;;^UTILITY(U,$J,358.3,58138,2)
+46 ;;=^5005911
+47 ;;^UTILITY(U,$J,358.3,58139,0)
+48 ;;=H40.62X0^^272^2901^38
+49 ;;^UTILITY(U,$J,358.3,58139,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,58139,1,3,0)
+52 ;;=3^Drug-Induced Glaucoma,Left Eye,Unspec Stage
+53 ;;^UTILITY(U,$J,358.3,58139,1,4,0)
+54 ;;=4^H40.62X0
+55 ;;^UTILITY(U,$J,358.3,58139,2)
+56 ;;=^5005910
+57 ;;^UTILITY(U,$J,358.3,58140,0)
+58 ;;=H40.62X2^^272^2901^36
+59 ;;^UTILITY(U,$J,358.3,58140,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,58140,1,3,0)
+62 ;;=3^Drug-Induced Glaucoma,Left Eye,Moderate Stage
+63 ;;^UTILITY(U,$J,358.3,58140,1,4,0)
+64 ;;=4^H40.62X2
+65 ;;^UTILITY(U,$J,358.3,58140,2)
+66 ;;=^5005912
+67 ;;^UTILITY(U,$J,358.3,58141,0)
+68 ;;=H40.62X3^^272^2901^37
+69 ;;^UTILITY(U,$J,358.3,58141,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,58141,1,3,0)
+72 ;;=3^Drug-Induced Glaucoma,Left Eye,Severe Stage
+73 ;;^UTILITY(U,$J,358.3,58141,1,4,0)
+74 ;;=4^H40.62X3
+75 ;;^UTILITY(U,$J,358.3,58141,2)
+76 ;;=^5133510
+77 ;;^UTILITY(U,$J,358.3,58142,0)
+78 ;;=H40.62X4^^272^2901^34
+79 ;;^UTILITY(U,$J,358.3,58142,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,58142,1,3,0)
+82 ;;=3^Drug-Induced Glaucoma,Left Eye,Indeterminate Stage
+83 ;;^UTILITY(U,$J,358.3,58142,1,4,0)
+84 ;;=4^H40.62X4
+85 ;;^UTILITY(U,$J,358.3,58142,2)
+86 ;;=^5005913
+87 ;;^UTILITY(U,$J,358.3,58143,0)
+88 ;;=H40.63X0^^272^2901^33
+89 ;;^UTILITY(U,$J,358.3,58143,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,58143,1,3,0)
+92 ;;=3^Drug-Induced Glaucoma,Bilateral,Unspec Stage
+93 ;;^UTILITY(U,$J,358.3,58143,1,4,0)
+94 ;;=4^H40.63X0
+95 ;;^UTILITY(U,$J,358.3,58143,2)
+96 ;;=^5005914
+97 ;;^UTILITY(U,$J,358.3,58144,0)
+98 ;;=H40.63X1^^272^2901^30
+99 ;;^UTILITY(U,$J,358.3,58144,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,58144,1,3,0)
+102 ;;=3^Drug-Induced Glaucoma,Bilateral,Mild Stage
+103 ;;^UTILITY(U,$J,358.3,58144,1,4,0)
+104 ;;=4^H40.63X1
+105 ;;^UTILITY(U,$J,358.3,58144,2)
+106 ;;=^5005915
+107 ;;^UTILITY(U,$J,358.3,58145,0)
+108 ;;=H40.63X2^^272^2901^31
+109 ;;^UTILITY(U,$J,358.3,58145,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,58145,1,3,0)
+112 ;;=3^Drug-Induced Glaucoma,Bilateral,Moderate Stage
+113 ;;^UTILITY(U,$J,358.3,58145,1,4,0)
+114 ;;=4^H40.63X2
+115 ;;^UTILITY(U,$J,358.3,58145,2)
+116 ;;=^5005916
+117 ;;^UTILITY(U,$J,358.3,58146,0)
+118 ;;=H40.63X3^^272^2901^32
+119 ;;^UTILITY(U,$J,358.3,58146,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,58146,1,3,0)
+122 ;;=3^Drug-Induced Glaucoma,Bilateral,Severe Stage
